MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Ocugen, Inc. (OCGN) on Wednesday reported a loss of $13.9 million in its fourth quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 5 cents.
The biotech knee implant developer posted revenue of $764,000 in the period.
For the year, the company reported a loss of $54 million, or 20 cents per share. Revenue was reported as $4.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCGN at https://www.zacks.com/ap/OCGN
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。